Loading

Please wait...

Tapazole

Generic Name: methimazole (me THIM a zole)
Brand Name: Tapazole
Physician reviewed Tapazole patient information - includes Tapazole description, dosage and directions.

Average Savings for methimazole (generic): 33.48%
  • Prescription Settings
  • X

Prices and coupons of Tapazole

Set your location
for drug prices near you

Enter your zip code


Please wait while the prices are loaded...

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
Tapazole prevents the Thyroid gland from producing too much Thyroid hormone. Tapazole is used to treat hyperThyroidism (overactive Thyroid). It is also used before Thyroid surgery or radioactive Iodine treatment. Tapazole may also be used for purposes not listed in this medication guide. You should not breast-feed while using Tapazole. You should not use Tapazole if you are allergic to it, or: if you are pregnant or breast-feeding. To make sure Tapazole is safe for you, tell your doctor if you have: Learn more

Tapazole Side Effects

Tapazole Side Effects

Note: This document contains side effect information about methimazole. Some of the dosage forms listed on this page may not apply to the brand name Tapazole.

For the Consumer

Applies to methimazole: oral tablet

Along with its needed effects, methimazole (the active ingredient contained in Tapazole) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking methimazole:

Rare

  • Backache
  • black, tarry stools
  • chest pain
  • chills
  • cough
  • fever
  • increase or decrease in urination
  • painful or difficult urination
  • shortness of breath
  • sore throat
  • sores, ulcers, or white spots on the lips or in the mouth
  • swelling of the feet or lower legs
  • swollen glands
  • unusual bleeding or bruising
  • unusual tiredness or weakness

Incidence not known

  • Abdominal or stomach pain
  • bleeding gums
  • blood in the urine or stool
  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • dark urine
  • difficulty with moving
  • general feeling of discomfort or weakness
  • headache
  • joint pain
  • light-colored stools
  • loss of appetite and weight
  • lower back or side pain
  • muscle aching or cramping
  • muscle pain or stiffness
  • nausea and vomiting
  • numbness or tingling of the hands, feet, or face
  • pinpoint red spots on the skin
  • sore muscles
  • swollen joints
  • swollen salivary glands
  • swollen, painful, or tender lymph glands in the neck, armpit, or groin
  • tightness in the chest
  • wheezing
  • yellow eyes or skin

Some side effects of methimazole may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

  • Abnormal loss of hair
  • dizziness or lightheadedness
  • feeling of constant movement of self or surroundings
  • heartburn
  • hives or welts
  • itching
  • loss of taste
  • pain or discomfort in the chest, upper stomach, or throat
  • red skin
  • skin rash
  • sleepiness
  • vomiting

For Healthcare Professionals

Applies to methimazole: compounding powder, oral tablet

General

Some of the more frequently reported adverse reactions have included skin rash, urticaria, nausea, loss of taste, and abnormal loss of hair.

Hematologic

The onset of aplastic anemia (pancytopenia) or agranulocytosis may occur in hours to days. Most cases of agranulocytosis occur within the first 90 days of treatment, but this complication can occur even a year or more after starting therapy.

Studies have suggested that the risk of agranulocytosis is greater in older patients and that they have a higher rate of death.

Frequency not reported: Lymphadenopathy, agranulocytosis, granulocytopenia, thrombocytopenia, aplastic anemia, hypoprothrombinemia

Immunologic

Frequency not reported: Lupus-like syndrome

Hepatic

Frequency not reported: Jaundice, hepatitis

Cardiovascular

Frequency not reported: Edema, periarteritis

Dermatologic

A 5-year-old female experienced aplasia cutis congenita coincident with in utero exposure to methimazole (the active ingredient contained in Tapazole) She presented with hairless scars on her scalp. At birth the lesions were friable and bled easily, however, over time they became scar-like and thicker. At the time of conception, her mother was receiving therapy for Graves' disease with methimazole 20 mg daily. Aplasia cutis congenita has been reported as a possible teratogenic effect of methimazole therapy in multiple case reports. However, the causal relationship between the therapy and the skin defect is controversial, and anomalies related to methimazole have low birth prevalence.

Frequency not reported: Skin rash, urticaria, abnormal loss of hair, pruritus, skin pigmentation

Musculoskeletal

Frequency not reported: Arthralgia, myalgia

Nervous system

Frequency not reported: Paresthesia, loss of taste, headache, drowsiness, neuritis

Gastrointestinal

Frequency not reported: Nausea, vomiting, epigastric distress, sialadenopathy

Renal

Very rare (less than 0.01%): Nephritis

Metabolic

Frequency not reported: Insulin autoimmune syndrome

Other

Frequency not reported: Vertigo, drug fever

Editorial References and Review

Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/1/2020.

Source: Drugs.com Tapazole (www.drugs.com/mtm/tapazole.html).